Key facts
- NINA Medical’s last known valuation is $10.0M (Sep 2025).
- It has raised $3.6M; the latest was Later Stage VC ($2.0M) in Dec 2025.
- Notable investors include Innovation Authority, Angels Capital, Chai inspirations, Mono Capital, Moshe Shoham — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for NINA Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for NINA Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NINA Medical
Developer of a non-invasive medical device designed to treat Benign Brostatic Hyperplasia. The company offers a transperineal High-Intensity Focused Ultrasound system with integrated ultrasound guidance, enabling patients with symptomatic prostate enlargement and their clinicians to perform targeted ablation without invasive access routes.
- Sector
- Healthcare
- HQ
- Netanya, Israel
- Founded
- 2019
- Employees
- 7
- Website
- ninamed.com/
- Ownership
- Privately Held (backing)
NINA Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NINA Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NINA Medical in its N-PORT filings yet. We sweep new filings monthly.